Acute Lung Injury clinical trials at UCSD
1 research study open to eligible people
The Safety and Preliminary Tolerability of Lyophilized Lucinactant in Adults With Coronavirus Disease 2019 (COVID-19)
open to eligible people ages 18-75
This is a multicenter, single-treatment study. Subjects will consist of adults with COVID-19 associated acute lung injury who are being cared for in a critical care environment.
La Jolla, California and other locations
Our lead scientists for Acute Lung Injury research studies include Robert Owens, MD.